Form 144 FENNEC PHARMACEUTICALS INC. For: 1 June
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Fennec Pharmaceuticals Inc (FRX)
Fennec Pharmaceuticals Inc stock price live, this page displays TSX FRX stock exchange data. View the FRX premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Fennec Pharmaceuticals Inc real time stock price chart below.
What Is the Fennec Pharmaceuticals Inc Stock Price Today?
The Fennec Pharmaceuticals Inc stock price today is 15.32.
What Is the Stock Symbol for Fennec Pharmaceuticals Inc?
The stock symbol for Fennec Pharmaceuticals Inc is "FRX."
What Stock Exchange Does Fennec Pharmaceuticals Inc Trade On?
Fennec Pharmaceuticals Inc is listed and trades on the Toronto stock exchange.
Is Fennec Pharmaceuticals Inc a Good Stock to Buy?
Determining whether Fennec Pharmaceuticals Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the FRX quote. (ISIN: CA31447P1009)
What Is the Fennec Pharmaceuticals Inc Stock Price Today?
The Fennec Pharmaceuticals Inc stock price today is 15.32.
What Is the Stock Symbol for Fennec Pharmaceuticals Inc?
The stock symbol for Fennec Pharmaceuticals Inc is "FRX."
What Stock Exchange Does Fennec Pharmaceuticals Inc Trade On?
Fennec Pharmaceuticals Inc is listed and trades on the Toronto stock exchange.
Is Fennec Pharmaceuticals Inc a Good Stock to Buy?
Determining whether Fennec Pharmaceuticals Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the FRX quote. (ISIN: CA31447P1009)
15.32
-0.10(-0.65%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
15.32
15.32
52 wk Range
7.59
15.48
FRX is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
15.3215.32
52 wk Range
7.5915.48
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
FRX Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Net income is expected to grow this year
- Form 13G FENNEC PHARMACEUTICALS INC. For: 14 May
- Investing.com
- Form 144 FENNEC PHARMACEUTICALS INC. For: 1 June
- Investing.com
- Form 8K FENNEC PHARMACEUTICALS INC. For: 18 May
- Investing.com
- Form 13G FENNEC PHARMACEUTICALS INC. For: 15 May
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Earnings
Latest Release
May 14, 2026
EPS / Forecast
0.01 / -0.04
Revenue / Forecast
15.1M / 14.65M
Compare FRX to Peers and Sector
Metrics to compare | FRX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipFRXPeersSector | |
|---|---|---|---|---|
P/E Ratio | −46.0x | −1.2x | −0.4x | |
PEG Ratio | −0.96 | −0.07 | 0.00 | |
Price/Book | 10.2x | 2.5x | 2.6x | |
Price / LTM Sales | 7.6x | 8.7x | 3.0x | |
Upside (Analyst Target) | - | 165.1% | 51.8% | |
Fair Value Upside | Unlock | 10.6% | 7.2% | Unlock |
Fennec Pharmaceuticals Inc. operates as a commercial stage biopharmaceutical company in the United States. The company’s product candidate includes PEDMARK, a formulation of sodium thiosulfate for the prevention of cisplatin-induced ototoxicity pediatric patients. It sells its products through regional pediatric oncology specialists and medical science liaisons. Fennec Pharmaceuticals Inc. has collaboration with Tampa General Hospital Foundation, Inc. for evaluation of clinical utility of sodium thiosulfate injection in reducing the risk of ototoxicity in adolescent, young adult, and adult cancer patients receiving cisplatin-based treatment; and Norgine Pharma UK Limited. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Fennec Pharma (FRX) Stock Price Today?
The Fennec Pharma stock price today is 15.32 CAD.
What Stock Exchange Does Fennec Pharma Trade On?
Fennec Pharma is listed and trades on the Toronto Stock Exchange.
What Is the Stock Symbol for Fennec Pharma?
The stock symbol for Fennec Pharma is "FRX."
What Is the Fennec Pharma Market Cap?
As of today, Fennec Pharma market cap is 532.17M CAD.
What Is Fennec Pharma's Earnings Per Share (TTM)?
The Fennec Pharma EPS (TTM) is -0.28.
When Is the Next Fennec Pharma Earnings Date?
Fennec Pharma will release its next earnings report on Aug 06, 2026.
From a Technical Analysis Perspective, Is FRX a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Fennec Pharma Stock Split?
Fennec Pharma has split 3 times.
How Many Employees Does Fennec Pharma Have?
Fennec Pharma has 35 employees.
What is the current trading status of Fennec Pharma (FRX)?
As of Jun 30, 2026, Fennec Pharma (FRX) is trading at a price of 15.32 CAD, with a previous close of 15.42 CAD. The stock has fluctuated within a day range of 15.32 CAD to 15.32 CAD, while its 52-week range spans from 7.59 CAD to 15.48 CAD.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.